REG - Essentra plc - Director/PDMR Shareholding

EssentraAnnouncement

06/10/2025 15:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251006:nRSF2529Ca&default-theme=true

RNS Number : 2529C  Essentra plc  06 October 2025

Essentra plc Director/PDMR Shareholding

Notification and public disclosure of transactions by persons discharging
managerial responsibility

Further to the announcement earlier today relating to the vesting of share
options, Scott Fawcett, Chief Executive Officer, and a Person Discharing
Managerial Responsibility ("PDMR") under article 19 of the Market Abuse
Regulation ("MAR"), has partially exercised share options to sell to cover, as
set out below.

Following the transaction, the resultant holding held by Scott Fawcett in
Essentra shares is 180,792 ordinary shares of 25 pence.

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Scott Fawcett

 2    Reason for the notification

      Transfer and sale of shares, pursuant to the satisfaction of the performance
      conditions, awarded under the Company's Long Term Incentive Plan Part B grant
      of September 2017 ("LTIP"), and the Deferred Annual Share Bonus scheme
      ("DASB").

 a)   Position/status                                              Chief Executive Officer

 b)   Initial notification /Amendment                              Initial

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Essentra plc

 b)   LEI                                                          5493007MOZNA03BVNE96

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary 25p shares

      Identification code                                          GB00B0744359

 b)   Nature of the transaction                                    Transfer and sale of shares

 c)   Price(s) and volume(s)                                                         Volume

                                                                                   Award date      Price (£)   Shares sold to settle tax liability  Balance of shares retained
                                                                                     LTIP
                                                                                     4October 2022  2.105       23,068*                              24,954
                                                                                     DASB
                                                                                     4October 2022  2.105       24,273*                              27,268
 d)   Aggregated information

      - Aggregated volume                                          As above
      - Price

 e)   Date of the transaction                                      6 October 2025

 f)   Place of the transaction                                     London Stock Exchange (XLON)

d)

 

Aggregated information

- Aggregated volume

As above

- Price

e)

 

Date of the transaction

 

 

6 October 2025

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

*Essentra operates a dividend reinvestment scheme ("DRIP") and accordingly the
following number of shares accumulated during the performance period and were
included in the transaction.

 LTIP  9,952
 DASB  9,280

For further enquiries, please contact

Essentra plc

Emma Reid

Company Secretary

T: + 44 (0) 1908 359100

 

6(th) October 2025

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUPGPCUUPAGCQ